We are live on ! Find out more
VKTXW

Viking Therapeutics, Inc.
VKTXW

Delisted

VKTXW was delisted on the 8th of April, 2021.

Back to rankings

1 hedge funds and large institutions have $53K invested in Viking Therapeutics, Inc. in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

4% more capital invested

Capital invested by funds: $51K → $53K (+$2K)

0% more funds holding

Funds holding: 1 → 1 (0)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
–
Calls
$83K
Puts
–
Net Calls
+$83K
Net Calls Change
+$30K

Top Buyers

No buyers this quarter

Top Sellers

1
SM
Sabby Management
Florida
-$26K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$53K -$26K -59,105 -34%

VKTXW Hedge Fund Activity: Q3 2016 in Review

1 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics, Inc. (VKTXW) for Q3 2016, worth a combined $53K — up 3.9% from $51K a quarter earlier.

Fund positioning in VKTXW was balanced in Q3 2016: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was Sabby Management, cutting an estimated $26K.

  • 1 institutional investor held Viking Therapeutics, Inc. (VKTXW) as of Q3 2016, unchanged from Q2 2016.
  • Funds reported $53K of Viking Therapeutics, Inc. stock for Q3 2016, up 3.9% quarter-over-quarter.
  • 0 funds opened new Viking Therapeutics, Inc. positions in Q3 2016 and 0 closed out.
  • The largest Viking Therapeutics, Inc. seller in Q3 2016 was Sabby Management, an estimated $26K sold.

Based on aggregated 13F filings for Q3 2016.